TAPBP and neoplasm: Second, neoantigen load is likely influenced by tumor mutation burden (TMB) and the efficiency of antigen processing and presentation machinery (e.g., TAP, tapasin, and immunoproteasome components), which are independent of HLA-II expression levels.